DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection  Dr Mihály Sulyok,

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Volume 357, Issue 9273, Pages (June 2001)
Volume 364, Issue 9440, Pages (September 2004)
Volume 359, Issue 9322, Pages (June 2002)
Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study  Oliver J Brady, DPhil, Hannah C Slater,
Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria:
Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa  Prof Tonya Renee Thurman,
Volume 372, Issue 9633, Pages (July 2008)
Total and cause-specific mortality before and after the onset of the Greek economic crisis: an interrupted time-series analysis  Ioannis Laliotis, PhD,
A mindfulness-based intervention to increase resilience to stress in university students (the Mindful Student Study): a pragmatic randomised controlled.
Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in.
The commercial determinants of health
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised.
Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard.
Volume 391, Issue 10130, Pages (April 2018)
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Volume 389, Issue 10076, Pages (April 2017)
Volume 371, Issue 9611, Pages (February 2008)
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum.
Volume 390, Issue 10092, Pages (July 2017)
Volume 372, Issue 9633, Pages (July 2008)
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax.
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study  Matthew Waxman, MD,
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel- group trial  Hood Thabit, PhD, Sara Hartnell, BSc, Janet M Allen,
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study 
Volume 389, Issue 10074, Pages (March 2017)
Volume 389, Issue 10071, Pages (February 2017)
The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study  Thuy-Nhien.
Nicola Low, Joost H Smid  The Lancet Public Health 
Volume 392, Issue 10147, Pages (August 2018)
Efficacy of chlorhexidine application to umbilical cord on neonatal mortality in Pemba, Tanzania: a community-based randomised controlled trial  Dr Sunil.
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study 
Volume 388, Issue 10061, Pages (December 2016)
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection  Dr Mihály Sulyok,
Volume 390, Issue 10092, Pages (July 2017)
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised,
Volume 392, Issue 10141, Pages (July 2018)
Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group,
Volume 5, Issue 11, Pages (November 2018)
Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised,
The effect of explosive remnants of war on global public health: a systematic mixed- studies review using narrative synthesis  Alexandra Frost, MSc, Prof.
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled.
Volume 4, Issue 6, Pages (June 2017)
Low-level lead exposure and mortality in US adults: a population-based cohort study  Prof Bruce P Lanphear, MD, Stephen Rauch, MPH, Peggy Auinger, MS,
Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study  Oliver J Brady, DPhil, Hannah C Slater,
Volume 389, Issue 10065, Pages (January 2017)
Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label,
Volume 388, Issue 10058, Pages (November 2016)
Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa  Prof Tonya Renee Thurman,
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Oral doxycycline for the prevention of postoperative trachomatous trichiasis in Ethiopia: a randomised, double-blind, placebo-controlled trial  Esmael.
Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim)
Thank you to our diverse (but not diverse enough) reviewers
Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin.
Effect of standard dose paracetamol versus placebo as antipyretic therapy on liver injury in adult dengue infection: a multicentre randomised controlled.
Volume 392, Issue 10160, Pages (November 2018)
Effect of a behaviour change intervention on the quality of peri-urban sanitation in Lusaka, Zambia: a randomised controlled trial  James B Tidwell, PhD,
Volume 5, Issue 1, Pages (January 2018)
Improving management of neonatal infections
Volume 383, Issue 9930, Pages (May 2014)
Volume 374, Issue 9694, Pages (September 2009)
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum.
Volume 371, Issue 9611, Pages (February 2008)
Volume 18, Issue 6, Pages (June 2019)
Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria:
Effect of strikes by health workers on mortality between 2010 and 2016 in Kilifi, Kenya: a population-based cohort analysis  Gerald Ong'ayo, MBChB, Michael.
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials  Andrew Clark, PhD, Kevin van Zandvoort,
Volume 394, Issue 10193, Pages (July 2019)
Sickle cell disease: a new era
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling  Gwenan M Knight, PhD, C Finn McQuaid,
Presentation transcript:

DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection  Dr Mihály Sulyok, MD, Thomas Rückle, PhD, Alexandra Roth, PhD, Raymund E Mürbeth, MD, Stephan Chalon, PhD, Nicola Kerr, BA(Mod), Sonia Schnieper Samec, PhD, Nathalie Gobeau, PhD, Carlos Lamsfus Calle, MSc, Javier Ibáñez, MSc, Zita Sulyok, MD, Jana Held, PhD, Tamirat Gebru, MSc, Patricia Granados, MSc, Sina Brückner, PhD, Christian Nguetse, PhD, Juliana Mengue, MSc, Albert Lalremruata, MSc, B Kim Lee Sim, PhD, Stephen L Hoffman, MD, Jörg J Möhrle, PhD, Prof Peter G Kremsner, MD, Benjamin Mordmüller, MD  The Lancet Infectious Diseases  Volume 17, Issue 6, Pages 636-644 (June 2017) DOI: 10.1016/S1473-3099(17)30139-1 Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license Terms and Conditions

Figure 1 Study design and main interventions Red curves show the expected DSM265 concentrations. MPC=minimal parasiticidal concentration. The Lancet Infectious Diseases 2017 17, 636-644DOI: (10.1016/S1473-3099(17)30139-1) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license Terms and Conditions

Figure 2 Trial profile ECG=electrocardiogram. ITT=intention to treat. PP=per protocol. The Lancet Infectious Diseases 2017 17, 636-644DOI: (10.1016/S1473-3099(17)30139-1) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license Terms and Conditions

Figure 3 Parasitaemia assessed by quantitative PCR Placebo volunteers (blue) and DSM265 volunteers (red). In cohort 1A, all DSM265 volunteers remained negative, in cohort 2 all became positive. M=malaria defined as positive thick blood smear. The Lancet Infectious Diseases 2017 17, 636-644DOI: (10.1016/S1473-3099(17)30139-1) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license Terms and Conditions

Figure 4 Concentration of DSM265 and DSM450 over time Individual (spaghetti) concentration–time profiles in plasma of DSM265 (A and C) and DSM450 (B and D) following administration of a single dose of 400 mg DSM265 in cohort 1 (A and B) and cohort 2 (C and D). Participants in cohort 2 (C) who developed malaria on days 11 and 13 are shown in red, the participant with malaria on day 24 is shown in blue, and participants with submicroscopic parasitaemia without malaria are shown in purple. The green shading shows the approximate time of the first cycle of asexual parasitaemia. The Lancet Infectious Diseases 2017 17, 636-644DOI: (10.1016/S1473-3099(17)30139-1) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license Terms and Conditions